China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial
- Posted on August 27, 2026
- By South China Morning Post
- 0 Views
- 1 min read
In brief
Generating AI summary…
China’s Akeso says cancer drug beat AstraZeneca’s Imfinzi in phase 3 trial
The biliary tract cancer trial is the latest breakthrough for Akeso’s ivonescimab, which has also shown promise in treating some lung cancers.
